Skip to main content
Clinical Trials/NCT06502041
NCT06502041CompletedNot Applicable

A Randomized Clinical Trial Comparing MARPE Effect With/Without MOP in Management of Skeletal Transverse Deficiency in Non-growing Patients

Mansoura University2 sites in 1 country24 target enrollmentStarted: September 5, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
2
Primary Endpoint
Stability of correction of transverse deficiency

Study Overview

Brief Summary

This study compares the effect of MARPE (mini-implant assisted rapid palatal expansion) versus MARPE+ MOP (Micro-osteo-perforation) on nasal airway and maxillary transverse deficiency in non-growing patients.

Detailed Description

All participants with skeletal transverse deficiency with unilateral or bilateral cross-bite aging 20-25 years were treated by expansion of maxillary arch as a first phase of treatment with one expander screw which was anchored to mini-implants placed in the palatal region (Mini-implant assissted rapid palatal expansion; MARPE). The patient's bone support in the anterior area of the palate was examined on CBCT. Micro-osteoperforation (MOP) was done along of medial palatine raphe in the intervention group. Control-group is the same of the intervention group but without micro-osteo-perforations.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Blinding of either patient or clinician is not possible. However, blinding was ensured during analyzing the data. All digital models and x-rays were coded and shuffled before they were evaluated and measured.

Eligibility Criteria

Ages
20 Years to 25 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The age ranges from 20-25 years.
  • Post pubertal adolescent
  • Skeletal transverse deficiency with unilateral or bilateral cross-bite
  • Extraction is not indicated in the lower arch.
  • Upper permanent dentition is erupted up to the second molars.
  • Average facial vertical growth pattern.
  • Space deficiency in the upper arch is less than 8 mm

Exclusion Criteria

  • Diseases and medications those are likely to affect bone biology.
  • Evidence of root resorption.
  • Poor oral hygiene.
  • Previous orthodontic treatment.
  • Evidence of bone loss.
  • Active periodontal disease.
  • Craniofacial congenital anomalies, such as cleft lip and palate.
  • Pregnant females.
  • Presence of oral habits.

Outcomes

Primary Outcomes

Stability of correction of transverse deficiency

Time Frame: about 6 months

by measuring the same CBCT transverse reading and by superimposition of the scaneed models at the end of the research

Pain experience during activation of expander by visual analogue scale ( VAS)

Time Frame: about 1 months

VAS: 0 ( no pain), 10 (unbearable pain)

Number of days till diastema appearance

Time Frame: about 1 month

(days)

Amount of skeletal expansion

Time Frame: about 1 month

(mm)

Skeletal, Dental & Nasal readings

Time Frame: measured before treatment and after 6 month of treatment

from CBCT and scanned models measured in degrees \& mm

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Motaz Elshehaby

principal investigator

Mansoura University

Study Sites (2)

Loading locations...

Similar Trials